Видео ютуба по тегу Olaparib

Dr. Robson on the Toxicity Profile of Olaparib in Breast Cancer
Dr. Robson on the Toxicity Profile of Olaparib in Breast Cancer
Olaparib in Ovarian Cancer
Olaparib in Ovarian Cancer
Case 2: Olaparib in BRCA-Mutated Ovarian Cancer
Case 2: Olaparib in BRCA-Mutated Ovarian Cancer
The story of olaparib: a life-saving cancer drug
The story of olaparib: a life-saving cancer drug
Olaparib Maintenance for Recurrent Ovarian Cancer
Olaparib Maintenance for Recurrent Ovarian Cancer
7-year OS from SOLO1: sustained benefit with maintenance olaparib
7-year OS from SOLO1: sustained benefit with maintenance olaparib
FDA D.I.S.C.O.: Olaparib for gBRCAm HER2-negative metastatic breast cancer
FDA D.I.S.C.O.: Olaparib for gBRCAm HER2-negative metastatic breast cancer
#ESMO21 Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
#ESMO21 Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
OlympiA: adjuvant olaparib in gBRCAm, HER2-negative, high-risk, early breast cancer
OlympiA: adjuvant olaparib in gBRCAm, HER2-negative, high-risk, early breast cancer
Exploring the use of olaparib in advanced breast cancer
Exploring the use of olaparib in advanced breast cancer
SOLO1: 7-Year Follow-up Highlights the Value of Maintenance Olaparib
SOLO1: 7-Year Follow-up Highlights the Value of Maintenance Olaparib
OlympiA: Adjuvant olaparib delays recurrence of BRCA-mutant breast cancer | Judy Garber
OlympiA: Adjuvant olaparib delays recurrence of BRCA-mutant breast cancer | Judy Garber
Anne talks about ovarian cancer and drug olaparib
Anne talks about ovarian cancer and drug olaparib
PARP Inhibitor Olaparib Exceeds Expectations in BRCA+ Pancreatic Cancer Management
PARP Inhibitor Olaparib Exceeds Expectations in BRCA+ Pancreatic Cancer Management
Olaparib Beneficial for BRCA-Mutated HER2-Negative Breast Cancer
Olaparib Beneficial for BRCA-Mutated HER2-Negative Breast Cancer
Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trial
Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trial
Olaparib Maintenance Therapy in Ovarian Cancer
Olaparib Maintenance Therapy in Ovarian Cancer
Dr. Tripathy on Impact of Olaparib Approval in BRCA-Positive Breast Cancer
Dr. Tripathy on Impact of Olaparib Approval in BRCA-Positive Breast Cancer
SOLO3 Highlights Toxicities With Olaparib in Ovarian Cancer
SOLO3 Highlights Toxicities With Olaparib in Ovarian Cancer